Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Studies suggesting potential link between insulin glargine and cancer prompt call for further research
American Pharmacists Association, 07/06/09
Three of four observational studies recently published in Diabetologia suggest an increased risk for cancer associated with use of insulin glargine. However, the authors of these studies cautioned against overinterpretation of their limited data and analyses, which prevented them from reaching definite conclusions. Patients with diabetes should not stop taking their insulin therapy, and patients should consult with their pharmacist if they have concerns about the medications they are taking.
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
International Journal of Clinical Oncology, 12/15/09
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Woman Previously Treated with Chemotherapy for Advanced Breast Cancer
Genentech, 12/15/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09
Tadalafil for the treatment of pulmonary arterial hypertension
Expert Opinion in Pharmacotherapy, 12/14/09
Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip
Arthritis Research & Therapy, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


